Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration

Acta ophthalmologica

Volumn 92, Issue 8, 2014, Pages 713-723

  Broadhead, Geoffrey K ^a   Hong, Thomas ^a   Chang, Andrew A ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

anti vascular endothelial growth factor; neovascular age related macular degeneration; refractory; treatment resistant

Indexed keywords

ANGIOGENESIS INHIBITOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANTAGONISTS AND INHIBITORS; DRUG COMBINATION; DRUG RESISTANCE; DRUG SUBSTITUTION; HUMAN; MULTIMODALITY CANCER THERAPY; WET MACULAR DEGENERATION;

ANGIOGENESIS INHIBITORS; COMBINED MODALITY THERAPY; DRUG RESISTANCE; DRUG SUBSTITUTION; DRUG THERAPY, COMBINATION; HUMANS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WET MACULAR DEGENERATION;

EID: 85027938688     PISSN: None     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12463     Document Type: Review

References (0)